Cellular Mechanisms in Mitral Valve Disease

[1]  M. Banach,et al.  Imbalance between pro-angiogenic and anti-angiogenic factors in rheumatic and mixomatous mitral valves. , 2011, International journal of cardiology.

[2]  Julia C. Swanson,et al.  Multiple mitral leaflet contractile systems in the beating heart. , 2011, Journal of biomechanics.

[3]  R. Levine,et al.  Mitral Valve Endothelial Cells With Osteogenic Differentiation Potential , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[4]  M. Longaker,et al.  Locally Applied Vascular Endothelial Growth Factor A Increases the Osteogenic Healing Capacity of Human Adipose‐Derived Stem Cells by Promoting Osteogenic and Endothelial Differentiation , 2011, Stem cells.

[5]  Julia C. Swanson,et al.  Electromechanical coupling between the atria and mitral valve. , 2011, American journal of physiology. Heart and circulatory physiology.

[6]  B. Corcoran,et al.  Molecular changes in fibrillar collagen in myxomatous mitral valve disease. , 2010, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[7]  N. Başar,et al.  Association of serum fetuin-A with valvular calcium concentration in rheumatic mitral valve disease. , 2010, The Journal of heart valve disease.

[8]  M. Prunotto,et al.  Cellular pathology of mitral valve prolapse. , 2010, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[9]  Jeffrey J Silbiger,et al.  Contemporary insights into the functional anatomy of the mitral valve. , 2009, American heart journal.

[10]  K. J. Grande-Allen,et al.  Significant Changes in Mitral Valve Leaflet Matrix Composition and Turnover With Tachycardia-Induced Cardiomyopathy , 2009, Circulation.

[11]  C. Yeh,et al.  Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease. , 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[12]  Suzanne Sullivan,et al.  Active Adaptation of the Tethered Mitral Valve: Insights Into a Compensatory Mechanism for Functional Mitral Regurgitation , 2009, Circulation.

[13]  J. Street,et al.  Vascular endothelial growth factor regulates osteoblast survival – evidence for an autocrine feedback mechanism , 2009, Journal of orthopaedic surgery and research.

[14]  Joseph Chen,et al.  Ultrastructure of porcine mitral valve chordae tendineae. , 2009, The Journal of heart valve disease.

[15]  R. Rothman,et al.  Serotonergic drugs and valvular heart disease , 2009, Expert opinion on drug safety.

[16]  Ajit P Yoganathan,et al.  Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. , 2009, Journal of the American College of Cardiology.

[17]  K. J. Grande-Allen,et al.  Effect of cyclic mechanical strain on glycosaminoglycan and proteoglycan synthesis by heart valve cells. , 2009, Acta biomaterialia.

[18]  H. Muresian.  The clinical anatomy of the mitral valve , 2009, Clinical anatomy.

[19]  J. Fisher,et al.  Computational simulation of oxygen diffusion in aortic valve leaflet for tissue engineering applications. , 2008, The Journal of heart valve disease.

[20]  F. Schoen.  Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering , 2008, Circulation.

[21]  Y. Okada,et al.  Local Tenomodulin Absence, Angiogenesis, and Matrix Metalloproteinase Activation Are Associated With the Rupture of the Chordae Tendineae Cordis , 2008, Circulation.

[22]  J. Yoshioka,et al.  Vascularization as a potential enemy in valvular heart disease. , 2008, Circulation.

[23]  K. J. Grande-Allen,et al.  The Effects of Mitral Regurgitation Alone Are Sufficient for Leaflet Remodeling , 2008, Circulation.

[24]  R. Levine,et al.  Mitral Leaflet Adaptation to Ventricular Remodeling: Occurrence and Adequacy in Patients With Functional Mitral Regurgitation , 2008, Circulation.

[25]  B. Carabello.  The current therapy for mitral regurgitation. , 2008, Journal of the American College of Cardiology.

[26]  M. Yacoub,et al.  Localisation and function of nerves in the aortic root. , 2008, Journal of molecular and cellular cardiology.

[27]  K. Jane Grande-Allen,et al.  Reversible Secretion of Glycosaminoglycans and Proteoglycans by Cyclically Stretched Valvular Cells in 3D Culture , 2008, Annals of Biomedical Engineering.

[28]  K. Donnelly.  Cardiac Valvular Pathology: Comparative Pathology and Animal Models of Acquired Cardiac Valvular Diseases , 2008, Toxicologic pathology.

[29]  H. Ostrer,et al.  The genetics of mitral valve prolapse , 2007, Clinical genetics.

[30]  A. Chester,et al.  Molecular and functional characteristics of heart-valve interstitial cells , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.

[31]  Martin Misfeld,et al.  Heart valve macro- and microstructure , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.

[32]  R. Levine,et al.  Molecular genetics of mitral valve prolapse , 2007, Current opinion in cardiology.

[33]  A. Antonini,et al.  Valvular heart disease and the use of dopamine agonists for Parkinson's disease. , 2007, The New England journal of medicine.

[34]  J. Veinot.  Pathology of inflammatory native valvular heart disease. , 2006, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[35]  J. Hemli,et al.  Methysergide-induced valvular heart disease: a report of 2 cases. , 2006, The heart surgery forum.

[36]  Paul Dagum,et al.  Mitral Leaflet Remodeling in Dilated Cardiomyopathy , 2006, Circulation.

[37]  R. Norris,et al.  Normal distribution of melanocytes in the mouse heart. , 2005, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[38]  Frederick J Schoen,et al.  Cardiac valves and valvular pathology: update on function, disease, repair, and replacement. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[39]  W. Edwards,et al.  Calcified Rheumatic Valve Neoangiogenesis Is Associated With Vascular Endothelial Growth Factor Expression and Osteoblast-Like Bone Formation , 2005, Circulation.

[40]  Craig A. Simmons,et al.  Spatial Heterogeneity of Endothelial Phenotypes Correlates With Side-Specific Vulnerability to Calcification in Normal Porcine Aortic Valves , 2005, Circulation research.

[41]  B. Griffin,et al.  Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study. , 2005, Journal of the American College of Cardiology.

[42]  David Liang,et al.  Importance of Mitral Valve Second-Order Chordae for Left Ventricular Geometry, Wall Thickening Mechanics, and Global Systolic Function , 2004, Circulation.

[43]  Joyce Bischoff,et al.  Heart valve development: endothelial cell signaling and differentiation. , 2004, Circulation research.

[44]  Frederick J Schoen,et al.  Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. , 2004, The Journal of heart valve disease.

[45]  Robert M Nerem,et al.  Unique Morphology and Focal Adhesion Development of Valvular Endothelial Cells in Static and Fluid Flow Environments , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[46]  J. Jew,et al.  Is the mitral valve passive flap theory overstated? An active valve is hypothesized. , 2004, Medical hypotheses.

[47]  Christopher G Ellis,et al.  A finite difference model of O2 transport in aortic valve cusps: importance of intrinsic microcirculation. , 2003, American journal of physiology. Heart and circulatory physiology.

[48]  B. Griffin,et al.  Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations. , 2003, Journal of the American College of Cardiology.

[49]  P. Hopkins,et al.  Risk of valvular heart disease associated with use of fenfluramine , 2003, BMC cardiovascular disorders.

[50]  Magdi H. Yacoub,et al.  The cardiac valve interstitial cell. , 2003, The international journal of biochemistry & cell biology.

[51]  R. Rothman.  Anorexogen-Related Cardiac Valvulopathy , 2002, Annals of Internal Medicine.

[52]  A. Gotlieb,et al.  Advances towards understanding heart valve response to injury. , 2002, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[53]  D R Boughner,et al.  Aortic valve cusp vessel density: relationship with tissue thickness. , 2002, The Journal of thoracic and cardiovascular surgery.

[54]  C. Ellis,et al.  Oxygen diffusion and consumption of aortic valve cusps. , 2001, American journal of physiology. Heart and circulatory physiology.

[55]  P. Libby,et al.  Activated Interstitial Myofibroblasts Express Catabolic Enzymes and Mediate Matrix Remodeling in Myxomatous Heart Valves , 2001, Circulation.

[56]  Y. Soini,et al.  Expression of MMP2, MMP9, MT1‐MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart , 2001, The Journal of pathology.

[57]  B. Roth,et al.  Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications , 2000, Circulation.

[58]  F J Schoen,et al.  Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. , 1999, Journal of biomedical materials research.

[59]  P J Kilner,et al.  The aortic outflow and root: a tale of dynamism and crosstalk. , 1999, The Annals of thoracic surgery.

[60]  M R de Leval,et al.  Innervation of human atrioventricular and arterial valves. , 1996, Circulation.

[61]  R E Pyeritz,et al.  Revised diagnostic criteria for the Marfan syndrome. , 1996, American journal of medical genetics.

[62]  J. Van Dorpe,et al.  Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature. , 1996, The Journal of heart valve disease.

[63]  V. Ferrans,et al.  Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. , 1995, American heart journal.

[64]  R. Padiyar,et al.  The role of displacement of the mitral annulus in left atrial filling and emptying in the intact dog. , 1978, Canadian journal of physiology and pharmacology.

[65]  HighWire Press.  Philosophical Transactions of the Royal Society of London , 1781, The London Medical Journal.

[66]  O. Alfieri,et al.  Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive? , 2009, Indian heart journal.

[67]  R. Rothman,et al.  Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA). , 2009, International review of neurobiology.

[68]  Joe S Mendez,et al.  Influence of strain on proteoglycan synthesis by valvular interstitial cells in three-dimensional culture. , 2008, Acta biomaterialia.

[69]  C. Simmons,et al.  Mechanobiology of the aortic heart valve. , 2008, The Journal of heart valve disease.

[70]  P. Biglioli,et al.  Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease , 2007, Clinical chemistry and laboratory medicine.

[71]  M. Yacoub,et al.  Cultured interstitial cells from human heart valves express both specific skeletal muscle and non-muscle markers. , 2006, The international journal of biochemistry & cell biology.